Last reviewed · How we verify
Reduction in antimetabolite immunosuppression
Reduction in antimetabolite immunosuppression is a Small molecule drug developed by University of California, Davis. It is currently FDA-approved.
At a glance
| Generic name | Reduction in antimetabolite immunosuppression |
|---|---|
| Sponsor | University of California, Davis |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Impact of Reduced Immunosuppression
- Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients (PHASE4)
- Using mTOR Inhibitors in the Prevention of BK Nephropathy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Reduction in antimetabolite immunosuppression CI brief — competitive landscape report
- Reduction in antimetabolite immunosuppression updates RSS · CI watch RSS
- University of California, Davis portfolio CI
Frequently asked questions about Reduction in antimetabolite immunosuppression
What is Reduction in antimetabolite immunosuppression?
Reduction in antimetabolite immunosuppression is a Small molecule drug developed by University of California, Davis.
Who makes Reduction in antimetabolite immunosuppression?
Reduction in antimetabolite immunosuppression is developed and marketed by University of California, Davis (see full University of California, Davis pipeline at /company/university-of-california-davis).
What development phase is Reduction in antimetabolite immunosuppression in?
Reduction in antimetabolite immunosuppression is FDA-approved (marketed).
Related
- Manufacturer: University of California, Davis — full pipeline